PE-22-28 (8mg)

Novel Rapid-Acting Antidepressant Compound

Blocks TREK-1 potassium channel for rapid antidepressant-like effects.

Research Applications & Benefits

What is PE-22-28?

Blocks TREK-1 potassium channel for rapid antidepressant-like effects.

Listed vial contents: 8mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.

What mechanisms are being studied?

PE-22-28 is a 7-amino acid peptide that acts as a specific antagonist of the TREK-1 potassium channel. TREK-1 is highly expressed in the brain and implicated in mood regulation — TREK-1 knockout mice display a robust antidepressant phenotype. By blocking TREK-1, PE-22-28 produces rapid antidepressant-like effects and promotes hippocampal neurogenesis.

What are the research questions?

  • Depression (treatment-resistant): Rapid antidepressant mechanism fundamentally different from SSRIs.
  • Neurogenesis: Promotes new neuron growth in hippocampus — the brain region most affected in depression.
  • Anxiety: TREK-1 antagonism has anxiolytic properties in preclinical models.

What does the published work describe?

Mazella J et al. — PE-22-28 (spadin) produced rapid antidepressant effects in behavioral despair and anhedonia models within 4 days (vs 2-3 weeks for SSRIs). Promoted hippocampal neurogenesis. Increased BDNF levels.

What are the limits of this evidence?

The research described concerns the cited experimental materials and models, not proof that this supplied vial is a treatment. Cell or animal findings do not establish human benefits. Clinical findings, where cited, apply to the tested formulation and population; they do not validate this research product for human use.

Study references

  1. Mazella J et al. Mol Pharmacol 2010

These are the catalog's existing bibliographic references. No new source verification is implied by this presentation.

How should I check lot documentation?

Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.

How is PE-22-28 handled in the lab?

Plan a PE-22-28 stock solution from the sequence, the listed molecular weight and, when reported for the same lot, net peptide content. Test-dissolve a small portion first, store the powder sealed, cold and dry, and split solutions into single-use aliquots. These are laboratory handling notes, not administration guidance.

Research Use Only. Not for human consumption, therapeutic, veterinary or any in-vivo use.

Product Specifications

Compound
PE-22-28
CAS Number
Molecular Weight
HPLC Purity Specification
≥98%
Category
Specialty
Starting Price
$89.00 USD
Country of Origin
United States
Shipping
Cold-chain insulated packaging, fast domestic delivery
Payment
Card, ACH, and cryptocurrency (10% discount)

Quality & Verification

PE-22-28 carries the purity specification shown above. Where a lot-specific CertikLabs Certificate of Analysis is available, the product page links its HPLC purity, LC-MS identity, and concentration results.

Frequently Asked Questions

Is PE-22-28 suitable for human consumption?

No. PE-22-28 is sold strictly for in-vitro laboratory research. It is not a drug, supplement, cosmetic, or food product and must not be administered to humans or animals.

What purity is PE-22-28?

PE-22-28 carries a ≥98% HPLC purity specification. Check the product page for an available lot report.

How is PE-22-28 shipped and stored?

Vials are shipped lyophilized in temperature-controlled packaging. Store unopened lyophilized peptide at −20°C; once reconstituted with bacteriostatic water, store at 2–8°C and use within 28 days.

Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.